a prospective randomized trial was conducted comparing the clinical response of 78 previously untreated patients with advanced metastatic breast cancer to a combination of cyclophosphamide , methotrexate , and 5-fluorouracil ( cmf ) or to a combination of cyclophosphamide , adriamycin , and 5-fluorouracil ( caf ) .
C0950521
cmf
C0016360
5-fluorouracil